Breast cancer is very expensive around the world.

Published Date: 16 Feb 2023

Study documents huge financial costs of breast cancer treatment for women in high and low/middle income countries and offers opportunities for intervention.

Read Full News

Latest News

How Green Are Prescriptions? New Data Offer Clues

Researchers provide one of the first estimates of the carbon footprint of primary care prescribing, offering data to support more environmentally sustainable medication use.

EMA Clears One Rare Brain Disease Therapy, Rejects Another

European regulators recommended a treatment for childhood cerebral adrenoleukodystrophy but refused one for Niemann-Pick disease type C.

EU Panel Backs First Refillable Eye Implant for AMD

Susvimo, a refillable ranibizumab implant for neovascular age-related macular degeneration, could reduce treatment burden by replacing monthly injections with 24-week refills.

Oral Cancer Screening Identifies Lesions, Follow-Up Lags

Mobile screening units identify oral mucosal lesions in 1 in 20 individuals in Hungary.

GP Follow-Up Tied to Higher Cervical Surveillance Loss

Patients with cervical precancerous lesions followed by general practitioners showed higher rates of missed surveillance appointments than those monitored by gynecologists.

EMA Recommends New Hematology and Supportive Care Drugs

Ruxolitinib Viatris and Cavoley moved closer to EU approval, offering a bioequivalent option for hematologic disease and a biosimilar to help prevent chemotherapy-related febrile neutropenia.

Todays Updates

Schizophrenia: Nighttime Light Tied to Metabolic Dysfunction

Higher vs lower nighttime light exposure is associated with increased risk for obesity, hypertension, and dyslipidemia in patients with schizophrenia, a study suggests.

Transperineal Biopsy IDs Active Surveillance Candidates

Transperineal 3D mapping biopsy may help select patients with low-risk prostate cancer who are most likely to fare well with active surveillance.

The Clues Hidden in Failed Prostate Cancer Trials

Many experts consider prostate cancer one of immunotherapy’s biggest disappointments. But a handful of patients don’t fit that narrative, and researchers are starting to uncover why.

Todays Updates

Schizophrenia: Nighttime Light Tied to Metabolic Dysfunction

Higher vs lower nighttime light exposure is associated with increased risk for obesity, hypertension, and dyslipidemia in patients with schizophrenia, a study suggests.

Transperineal Biopsy IDs Active Surveillance Candidates

Transperineal 3D mapping biopsy may help select patients with low-risk prostate cancer who are most likely to fare well with active surveillance.

The Clues Hidden in Failed Prostate Cancer Trials

Many experts consider prostate cancer one of immunotherapy’s biggest disappointments. But a handful of patients don’t fit that narrative, and researchers are starting to uncover why.

Latest News

Researchers provide one of the first estimates of the carbon footprint of primary care prescribing, offering data to support more environmentally sustainable medication use.

European regulators recommended a treatment for childhood cerebral adrenoleukodystrophy but refused one for Niemann-Pick disease type C.

Susvimo, a refillable ranibizumab implant for neovascular age-related macular degeneration, could reduce treatment burden by replacing monthly injections with 24-week refills.

Mobile screening units identify oral mucosal lesions in 1 in 20 individuals in Hungary.

Patients with cervical precancerous lesions followed by general practitioners showed higher rates of missed surveillance appointments than those monitored by gynecologists.

Ruxolitinib Viatris and Cavoley moved closer to EU approval, offering a bioequivalent option for hematologic disease and a biosimilar to help prevent chemotherapy-related febrile neutropenia.

News All Time

HTTP error: 503HTTP error: 503

First MS Mobility Drug Gets Green Light From NHS England

NHS England reverses a 2022 NICE rejection now fampridine is off patent, bringing England into line with the rest of the UK.

Why Oropouche Virus Is Gaining Global Attention

Researchers report rapid spread, widespread underdiagnosis, and growing travel-associated infections, raising concerns about future outbreaks beyond Latin America.

Pharmacies Left Out as Pubs Get Rates Cut

Pharmacy associations criticise the government's decision to offer another business rates cut to pubs and live music venues while excluding high street pharmacies again.
HTTP error: 503

To Treat or Not to Treat? The COVID Conundrum

A 31-year-old presents with COVID and wants medication to fight the infection. Dr Chuck Vega weighs in on the evidence for standard-risk patients.

All Quiet on the Vaccine Front?

While public support for vaccines remains strong, quieter efforts to weaken vaccine policy, compensation programs, and scientific oversight are gaining ground. Here's what physicians need to know.

Both Sides of the Bars: Jail Reform as Mental Health Policy

Jails have become de facto psychiatric institutions. Dr Temitope Ogundare explains why psychiatrists should help prevent incarceration — not just treat its consequences.
HTTP error: 503HTTP error: 503HTTP error: 503

Microteams Tied to Better Continuity of Care in Primary Care

Implementation of a microteams model is associated with an increase in consultations with GPs, indicating improved continuity of care.

Parkinson's Care Gaps: Do Immigrant Patients Face Barriers?

Immigrant patients with Parkinson's disease have clinical profiles similar to native patients but are less likely to attend follow-up visits and adhere to treatment, a Spanish study shows.

Indigenous Canadians Face Cancer Survival Inequalities

Breast, colon, and cervical cancer incidence and mortality have improved for First Nations patients, but survival is significantly lower than that of other Ontario residents.
HTTP error: 503

Recommended News For You

Recommended Articles For You

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Doxorubicin-Trabectedin Strategy Boosts Survival in Challenging Sarcoma

2.

Mosunetuzumab in Follicular Lymphoma: Durable Responses and Manageable Safety

3.

Which Salvage Therapy Is Best for Recurrent Prostate Cancer?

4.

Belzutifan Plus Pembro Approved for Adjuvant RCC

5.

investigating radiation oncology applications of artificial general intelligence.

1.

Exploring the Causes and Treatments of Cysts: A Comprehensive Guide

2.

Hemophilia Beyond Boundaries: Unconventional Therapies in Bleeding Disorder Care

3.

Strategic Standards in Hematology for Specialists

4.

Iron Metabolism and Inflammatory Disorders: Mechanisms, Clinical Implications, and Therapeutic Approaches

5.

First-Line Immuno-Hematology Examinations: Essential Diagnostic Tools for Patient Care

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part I

2.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VI

3.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part II

4.

Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part I

5.

Navigating the Complexities of Ph Negative ALL - Part XV

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot